AMSTERDAM: BenevolentAI (Euronext Amsterdam: BAI), a leader in AI-driven drug discovery, announced plans to delist from Euronext Amsterdam via a merger with Osaka Holdings S.à r.l., a private entity. This move, subject to shareholder approval, aims to simplify the company’s structure and reduce administrative overhead. Following an extensive review, the Board concluded that the costs…